Latest News and Press Releases
Want to stay updated on the latest news?
-
SAN RAFAEL, Calif., April 27, 2015 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced completion of the rolling submission of a New Drug Application (NDA) to the United...
-
Interim analysis of prospective natural history increases understanding of Duchenne muscular dystrophy BioMarin to present data from seven abstracts on Duchenne and Huntington's disease at AAN...
-
SAN RAFAEL, Calif., April 21, 2015 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that on April 15, 2015, the compensation committee of BioMarin's board of directors...
-
SAN RAFAEL, Calif., April 14, 2015 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jean-Jacques Bienaimé, Chief Executive Officer of BioMarin, will host a...
-
SAN RAFAEL, Calif., March 30, 2015 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced the results of a post-hoc sub-analysis of the PKU-016 or ASCEND study, the largest...
-
SAN RAFAEL, Calif., March 18, 2015 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that on March 16, 2015, the compensation committee of BioMarin's board of directors...
-
Total BioMarin Revenue Increased 37% to $751 million in 2014 Rolling Submission of NDA for Drisapersen Underway; Acquisition of Prosensa Complete Financial Highlights ($ in millions, except per...
-
SAN RAFAEL, Calif., Feb. 20, 2015 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that on February 17, 2015, the compensation committee of BioMarin's board of directors...
-
LEIDEN, The Netherlands, Feb. 10, 2015 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (Nasdaq:RNA) ("Prosensa" or the "Company"), the biopharmaceutical company focusing on RNA-modulating therapeutics for...
-
SAN RAFAEL, Calif., Feb. 9, 2015 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today that the company would make two data presenations in addition to presenting eight...